Fred E Cohen

CIK 1339358 · last filed 2026-06-10

Fred E Cohen is a corporate insider who has filed 163 SEC Form 4 insider transactions across 12 companies since 2007. The most recent filing, for NTLA, was dated Jun 10, 2026. Across all open-market trades the lifetime net is −$3.6M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $47.9M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$47.90M

Companies

12

Total Filings

163

Lifetime Open-Market Net

-$3.60M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
NTLA Director 216,653 $12.11 $2.62M $1.40M 12 2026-06-10
KYTX Director 4,545,651 $8.05 $36.62M $0 3 2026-05-29
CDNA Director 155,265 $22.97 $3.57M $0 33 2025-06-17
URGN Director 84,339 $29.72 $2.51M $0 8 2024-08-08
PGNY Director 22,693 $26.63 $604.3K $0 6 2024-05-28
VCYT Director 10,000 $47.33 $473.3K -$1.07M 9 2020-10-20
GENOMIC HEALTH INC (GHDX) Delisted Director 75,188 -$3.63M 57 2019-10-03
TNDM Director $16.60 $0 7 2018-11-19
BCRX Director 173,660 $8.70 $1.51M -$294.0K 19 2018-06-22
Roka BioScience, Inc. (ROKA) Delisted Director $0 3 2017-06-30
FIVE PRIME THERAPEUTICS, INC. (XLRN) Delisted Director $178.75 $0 2 2017-05-12
FIVE PRIME THERAPEUTICS, INC. (FPRX) Delisted Director 24,807 $38.00 $942.7K $0 3 2016-01-13

Recent Filings

163 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2026-06-10 NTLA Grant (A) +9,200 $0 EDGAR
2026-05-29 KYTX Grant (A) +5,093 $0 EDGAR
2026-01-07 NTLA Buy (P) +150,000 $1.40M EDGAR
2025-06-17 CDNA Grant (A) +12,103 $0 EDGAR
2025-06-13 NTLA Grant (A) +8,000 $0 EDGAR
2025-06-02 KYTX Grant (A) +16,634 $0 EDGAR
2024-08-08 URGN Grant (A) $0 EDGAR
2024-06-20 CDNA Grant (A) $0 EDGAR
2024-06-18 CDNA Grant (A) +10,570 $0 EDGAR
2024-06-14 NTLA Grant (A) +7,737 $0 EDGAR
Showing 110 of 163
Page 1 of 17
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.